VBI Vaccines Announces European Commission Marketing Authorisation for PreHevbri™, a 3-Antigen Adult Hepatitis B Vaccine - Yahoo Finance

Submitted by Anonymous (not verified) on Mon, 05/02/2022 - 12:00

VBI Vaccines Announces European Commission Marketing Authorisation for PreHevbri™, a 3-Antigen Adult Hepatitis B Vaccine  Yahoo Finance